← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 12, 2020Last known activity
Sep 27, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 10 trials)
Phase 3 (3 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT06320353CollaboratorPhase 3Sep 27, 2023
- NCT06440746CollaboratorPhase 2/Phase 3Aug 23, 2023
- NCT06307093CollaboratorPhase 1Mar 1, 2023
- NCT05432960CollaboratorPhase 3Aug 31, 2022
- NCT05107934CollaboratorPhase 2/Phase 3Mar 1, 2022
- NCT05190991CollaboratorPhase 2Oct 5, 2021
- NCT05092776CollaboratorPhase 2Apr 29, 2021
- NCT05673902CollaboratorPhase 3Dec 11, 2020
- NCT04463251CollaboratorPhase 2Nov 1, 2020
- NCT04692766CollaboratorPhase 2/Phase 3Feb 12, 2020
Details
- Last known activity
- Sep 27, 2023